Skip to main content

Advertisement

SpringerLink
Log in

The association of adiponectin serum level and ADIPOQ +45 T/G and ADIPOR1 −106 A/G gene polymorphisms with diabetic nephropathy in type 2 DM

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Adiponectin encoded by ADIPOQ, gene (adiponectin, C1Q and Collagen Domain-Containing) is an adipocyte-derived protein, plays a major role in mediating insulin sensitivity, and lower plasma adiponectin concentration has been linked to microangiopathies in type 2 diabetes mellitus (DM). It has been hypothesized that blood adiponectin concentration may reflect the extent of kidney damage in diabetic patients. Our aim was to study genetic polymorphisms in adiponectin genes (ADIPOQ +45 T/G and adiponectin receptor 1 (ADIPOR1) −106 A/G) and the serum level of adiponectin in type 2 DM and to correlate this with the stages of diabetic nephropathy. Forty-eight patients with type 2 DM were recruited from Internal Medicine Department and Nephrology Outpatient Clinic in Kasr El Aini Hospital, Cairo University, from April 2011 until March 2012. They were divided into normoalbuminuric (nonnephropathic), n = 17; and nephropathic group, n = 31; who were further subdivided into microalbuminuric, macroalbuminuric, and end-stage renal disease groups. They were compared to ten healthy control subjects. Blood urea, creatinine, HbA1c, and adiponectin were measured. ADIPOQ +45 T/G and ADIPOR1 −106 A/G gene polymorphisms were analyzed by PCR RFLP. Serum adiponectin was significantly lower in nephropathic group versus nonnephropathic and control group (P = 0.026) with the lowest level in macroalbuminuric group (P < 0.001). Serum urea, blood glucose, HbA1c, and duration of diabetes were found to be independent predictors of adiponectin level, r 2 = 0.59. In case of ADIPOQ, most of the cases carried the TT genotype, and there was absence of GG genotype in both cases and control. The ADIPOR1 gene polymorphism was strongly associated with type 2 DM and diabetic nephropathy. The G allele of ADIPOR1 was found to be a risk factor for type 2 DM with OR 3.1 (95 % confidence interval 1.1–8.5), P = 0.028. This evidence highlights the role of ADIPOR1 in the pathogenesis of diabetic nephropathy and type 2 diabetes (T2D), suggesting AdipoR1 as a promising target for the treatment of T2D patients, particularly those who have microalbuminuria. Also, adiponectin serum level is a biomarker for kidney disease and may be targeted for prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ahima RS (2008) Linking adiponectin to proteinuria. J Clin Invest 118(5):1645–1656

    Google Scholar 

  • American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31:S55–S60

    Article  Google Scholar 

  • An WS, Son YK, Kim SE, Kim KH, Bae HR, Lee S, Park Y, Kim HJ, Vaziri ND (2011) Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients. Clin Nephrol 75(3):195–203

    Article  CAS  PubMed  Google Scholar 

  • Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4:444–452

    Article  CAS  PubMed  Google Scholar 

  • Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, Legge DG, Quan H, Zhao MM, Ning N, Kang Z (2011) Associations between single-nucleotide polymorphisms (+45 T > G, +276G > T, −11377C > G, −11391G > A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54(9):2303–2314, Epub 2011 Jun 3

    Article  CAS  PubMed  Google Scholar 

  • Hattersley AT, Pearson ER (2006) Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 147:2657–2663

    Article  CAS  PubMed  Google Scholar 

  • Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose specific gene dysregulated in obesity. J Biol Chem 271:10697–10703

    Article  CAS  PubMed  Google Scholar 

  • Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451

    Article  CAS  PubMed  Google Scholar 

  • Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F (2007) Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 71:1279–1286

    Article  CAS  PubMed  Google Scholar 

  • Lee YJ, Cho S, Kim SR (2011) The association between serum adiponectin levels and nutritional status of hemodialysis patients. Ren Fail 33(5):506–511

    Article  CAS  PubMed  Google Scholar 

  • Levey AS, Stevens LA (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    Article  PubMed Central  PubMed  Google Scholar 

  • Looker HC, Krakoff J, Funahashi T et al (2004) Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89:4010–4017

    Article  CAS  PubMed  Google Scholar 

  • Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221:286–289

    Article  CAS  PubMed  Google Scholar 

  • Mather KJ, Christophi CA, Jablonski KA, Knowler WC, Goldberg RB et al (2012) Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program. Diabet Med. doi:10.1111/j.1464-5491

  • Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T (1995) The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 12:482–487

    Article  CAS  PubMed  Google Scholar 

  • Mogensen CE, Chachati A, Christensen CK et al (1985) Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9:85–95

    PubMed  Google Scholar 

  • Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S et al (2006) Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131:853–861

    Article  CAS  PubMed  Google Scholar 

  • Ouchi N, Kihara S, Arita Y, Okamato Y, Maeda K, Kuriyama H et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signalling through a cAMP-dependent pathway. Circulation 102:1296–1301

    Article  CAS  PubMed  Google Scholar 

  • Parving H-H, Gall M-A, Skøtt P et al (1992) Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758–762

    Article  CAS  PubMed  Google Scholar 

  • Potapov VA, Chistiakov DA, Dubinina A, Shamkhalova MS, Shestakova MV, Nosikov VN (2008) Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev Diabet Stud 5(1):28–37, Spring

    Article  PubMed Central  PubMed  Google Scholar 

  • Remuzzi G, Schieppati A, Ruggenenti P (2002) Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 346:1145–1151

    Article  PubMed  Google Scholar 

  • Ryan AS, Berman DM, Nicklas BJ et al (2003) Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26:2383–2388

    Article  CAS  PubMed  Google Scholar 

  • Sale MM, Freedman BI (2006) Genetic determinants of albuminuria and renal disease in diabetes mellitus. Nephrol Dial Transplant 21:13–16

    Article  CAS  PubMed  Google Scholar 

  • Sharma K, Ramachandra RS, Qiu G, Usui HK, Zhu Y et al (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118:1645–1656

    CAS  PubMed Central  PubMed  Google Scholar 

  • Siitonen N, Pulkkinen L, Mager U, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaaniemi S, Tuomilehto J et al (2006) Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia 49:1795–1805

    Article  CAS  PubMed  Google Scholar 

  • Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S et al (2004) Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 65:274–281

    Article  CAS  PubMed  Google Scholar 

  • Vasseur F, Meyre D, Froguel P (2006) Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med 8:1–12

    Article  PubMed  Google Scholar 

  • Vaxillaire M, Dechaume A, Vasseur-Delannoy V, Lahmidi S, Vatin V, Lepretre F, Boutin P, Hercberg S, Charpentier G, Dina C et al (2006) Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population. Diabetes 55:856–861

    Article  CAS  PubMed  Google Scholar 

  • Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935

    CAS  PubMed  Google Scholar 

  • Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769

    Article  CAS  PubMed  Google Scholar 

  • Yano Y, Hoshide S, Ishikawa J et al (2007) Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens 9:775–782 (Greenwich)

    Article  CAS  Google Scholar 

  • Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Eyileten T et al (2008) Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant 23:1621–1627

    Article  CAS  PubMed  Google Scholar 

  • Yoshioka K, Yoshida T, Umekawa T, Kogure A, Takakura Y, Toda H, Yoshikawa T (2004) Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients. Metabolism 53(9):1223–1226

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt

    Manal Kamal

  2. Department of Internal Medicine, Cairo University, Cairo, Egypt

    Mona Roshdy & Mohamed ElKhatib

Authors
  1. Manal Kamal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona Roshdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed ElKhatib
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manal Kamal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamal, M., Roshdy, M. & ElKhatib, M. The association of adiponectin serum level and ADIPOQ +45 T/G and ADIPOR1 −106 A/G gene polymorphisms with diabetic nephropathy in type 2 DM. Comp Clin Pathol 23, 53–60 (2014). https://doi.org/10.1007/s00580-012-1569-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-012-1569-4

Keywords

Search

Navigation